Mayo Clinic Breakthrough: AI Detects Pancreatic Cancer Up to 3 Years Early Using CT Scans
Mayo Clinic researchers developed an AI tool that can identify early pancreatic cancer in routine CT scans up to three years before symptoms appear, detecting prediagnostic cancers at nearly double the rate of specialist radiologists. This breakthrough could dramatically improve survival rates for one of the deadliest cancers.
AI-Assisted Cancer Detection
Mayo's new tool helped doctors detect prediagnostic cancers at nearly double the rate of specialists examining the scans without using AI. The study showed scans obtained and reviewed by the AI tool more than two years before an official diagnosis were three times more effective in identifying early cancers.
Research Details
The study, which was published in the medical journal Gut, reviewed approximately 2,000 CT scans, including those from patients later diagnosed with pancreatic cancer.
Clinical Significance
Mayo Clinic's AI-assisted test model can detect pancreatic cancer up to three years early, offering patients more time for curative treatment.
Precure Initiative
Researchers completed the study as part of the Mayo Clinic's Precure initiative, a program intended to help health care providers predict and prevent diseases by learning early biological changes in the body — before symptoms begin.
Impact
Pancreatic cancer remains one of the deadliest cancers with historically poor survival rates, making early detection a critical advancement in cancer care.